Drug Sales Trends for INDOCIN

Annual Sales Revenues and Units Sold for INDOCIN

These sales figures are drawn from a US national survey of drug expenditures

Drug Name	Revenues (USD)	Units	Year
INDOCIN			2021
INDOCIN			2020
INDOCIN			2019
INDOCIN			2018
INDOCIN			2017
INDOCIN			2016

Indomethacin (Indocin) Market Analysis and Sales Projections

Market Introduction

Indomethacin, marketed under the brand name Indocin, is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and swelling in patients suffering from arthritis, bursitis, gout, tendonitis, and other inflammatory conditions. It works by blocking substances in the body that cause inflammation, thereby preventing pain and swelling[1].

Market Dynamics

The indomethacin market is driven by several key factors:

• Increasing Prevalence of Chronic Conditions: The rising prevalence of gout and arthritis, along with a growing focus on treating these and other chronic conditions, is a significant driver of the market[1].
• Pharmaceutical Industry Growth: The expanding pharmaceutical industry in developing nations is expected to create substantial growth opportunities[1].
• Generic Competition: However, the market also faces challenges such as generic competition, which can impact sales volume and pricing. For instance, Assertio reported a decrease in Indocin net product sales in the first quarter of 2024 due to generic competition[5].

Market Segmentation

The indomethacin market is segmented based on several criteria:

• Type: The market is segmented into indomethacin tablets, capsules, suppositories, injections, patches, gelatin pearls, creams, and other forms. The indomethacin tablet segment accounted for a noticeable share of the global market in 2023 and is projected to experience significant growth in the near future[4].
• Age Group: The market is segmented into children and adults. The children segment is expected to expand at a significant CAGR throughout the forecast period[4].
• Distribution Channel: The market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies[1].

Regional Framework

The indomethacin market is analyzed across five major regions:

• North America: This region includes the US and Canada, with the US & Canada market for indomethacin expected to grow at a notable CAGR from 2025 to 2030[2].
• Europe: The European market is also expected to increase, driven by the growing demand for NSAIDs in treating chronic pain conditions[2].
• Asia-Pacific (APAC): The APAC region, including countries like China, Japan, and South Korea, is anticipated to show significant growth due to the expanding pharmaceutical industry and increasing prevalence of chronic diseases[2][4].
• Middle East and Africa (MEA) and South & Central America: These regions are also expected to contribute to the market growth, albeit at a slower pace compared to other regions[1][4].

Sales Projections

Global Market

• The global indomethacin market is expected to witness high growth during the forecast period from 2023 to 2031. The market size is anticipated to reach USD XX billion by 2031, growing at a compound annual growth rate (CAGR) of XX%[3][4].

Regional Sales

• US & Canada: The market in this region is estimated to increase from $XX million in 2024 to $XX million by 2030, at a CAGR of XX% during the forecast period[2].
• Europe: The European market is expected to grow similarly, with a CAGR of XX% from 2025 to 2030[2].
• China: The Chinese market is projected to increase from $XX million in 2024 to $XX million by 2030, at a CAGR of XX% during the forecast period[2].

Key Manufacturers

The global key manufacturers of indomethacin include Ratiopharm, Merck, Xinhua Pharma, Hotai Pharma, Konch Pharma, and Ouyi Pharma. In 2023, the global top five players had a significant share in terms of revenue[2].

Market Trends and Opportunities

• Growing Demand for NSAIDs: The increasing demand for NSAIDs in treating chronic pain conditions is a major trend driving the market[1].
• Technological Advancements: Innovations in drug delivery systems, such as patches and gelatin pearls, are providing new opportunities for market growth[3].
• Expanding Pharmaceutical Industry: The growth of the pharmaceutical industry in developing nations is creating new market opportunities[1].

Challenges

• Generic Competition: As seen with Assertio's Indocin sales, generic competition can significantly impact the market by reducing sales volume and pricing[5].
• Side Effects and Safety Concerns: NSAIDs, including indomethacin, can have side effects such as gastrointestinal issues and cardiovascular risks, which can affect market growth[1].

Competitive Landscape

The competitive landscape of the indomethacin market is highly competitive, with several key players focusing on strategy building and product portfolio expansion. Companies like Ratiopharm and Xinhua Pharma are actively working to strengthen their market positions[4].

Financial Performance

• Assertio's Financials: In the first quarter of 2024, Indocin net product sales were $8.7 million, down from $10.8 million in the fourth quarter of 2023, due to generic competition. This highlights the impact of competition on the financial performance of key players[5].

Key Takeaways

• The indomethacin market is driven by the increasing prevalence of chronic conditions and the growing pharmaceutical industry.
• The market is segmented by type, age group, and distribution channel.
• Regional growth is significant in North America, Europe, and APAC.
• Key manufacturers include Ratiopharm, Merck, and Xinhua Pharma.
• Generic competition and side effects are major challenges.
• Technological advancements and expanding pharmaceutical industries present opportunities.

FAQs

What is indomethacin used for?

Indomethacin is used to relieve pain and swelling in patients suffering from arthritis, bursitis, gout, tendonitis, and other inflammatory conditions.

Which regions are expected to drive the growth of the indomethacin market?

The North America, Europe, and Asia-Pacific regions are expected to drive the growth of the indomethacin market due to the increasing prevalence of chronic conditions and the expanding pharmaceutical industry.

What are the main types of indomethacin products?

The main types of indomethacin products include tablets, capsules, suppositories, injections, patches, gelatin pearls, and creams.

Who are the key manufacturers in the indomethacin market?

Key manufacturers include Ratiopharm, Merck, Xinhua Pharma, Hotai Pharma, Konch Pharma, and Ouyi Pharma.

How does generic competition affect the indomethacin market?

Generic competition can significantly reduce sales volume and pricing, as seen with Assertio's Indocin sales, which decreased due to generic competition.

Sources

1. The Insight Partners - Indomethacin Market Insights and Growth by 2031
2. QY Research - Global Indomethacin Market Insights, Forecast to 2030
3. Market Research Intellect - Indometacin (Indomethacin) Market Size, Scope And Forecast Report
4. Cognitive Market Research - Indomethacin Market Report 2025 (Global Edition)
5. BioSpace - Assertio Reports First Quarter 2024 Financial Results